Cytokinetics heart drug wins FDA approval, the biotech’s first The clearance of Myqorzo ends one of the longest industry’s R&D droughts in the industry

https://www.statnews.com/2025/12/19/cytokinetics-heart-drug-myqorzo-fda-approval/ By Adam FeuersteinDec. 19, 2025 Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and biotechnology.